Gyre Therapeutics (GYRE) Prepaid Assets (2010 - 2026)

Gyre Therapeutics (GYRE) has reported Prepaid Assets for 17 consecutive years, with $3.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets fell 53.9% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (down 53.9% YoY), while the FY2025 annual figure was $2.8 million, up 137.76% from the prior year.
• Prepaid Assets rose to $3.8 million in Q1 2026 per GYRE's latest filing, from $2.8 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $8.2 million in Q1 2025 and bottomed at $697000.0 in Q2 2023.
• Historically, Prepaid Assets has averaged $2.1 million across 5 years, with a median of $1.3 million in 2022.
• Annual changes were most pronounced in 2022 — Prepaid Assets plunged 89.03% — and 2025, when it soared 355.92%.
• Gyre Therapeutics' Prepaid Assets stood at $843000.0 in 2022, then grew by 23.96% to $1.0 million in 2023, then gained by 13.78% to $1.2 million in 2024, then soared by 137.76% to $2.8 million in 2025, then jumped by 33.07% to $3.8 million in 2026.
• Business Quant data shows GYRE's Prepaid Assets at $3.8 million in Q1 2026, $2.8 million in Q4 2025, and $2.9 million in Q3 2025.